H e m o l y t i c    A n e m i a


Causes
Inherited
1. Defects in red blood cell membrane
   •  Hereditary spherocytosis
2. Enzyme deficiencies
   •  Glucose-6-phosphate dehydrogenase deficiency
3. Defects in globin structure/synthesis
   •  Hemoglobinopathies (e.g., sickle cell anemia)
   •  Thalassemias

Acquired
1. Autoimmune hemolytic anemia
2. Microangiopathic hemolytic anemia
3. Infection-related
  •  Protozoa (e.g., malaria, babesia)
  •  Bacteria (e.g., clostridia, typhoid fever)
   
Clinical Features
Chronic hemolytic anemias
•  Usually congenital
•  Sometimes well-compensated (bone marrow increases red cell production
   to offset the hemolysis), with few symptoms (until a crisis happens).
•  Crises (due to fragile equilibrium between red cell destruction and bone
   marrow compensation)
   •  Usually precipitated by infection (especially common: parvovirus B19).
   •  Parvovirus attacks red cells; the already maxed-out bone marrow
      cannot compensate!
•  Splenomegaly
•  Jaundice (increased unconjugated bilirubin)
•  Gallstones (unclear pathophysiologic reasons)

Acute hemolytic anemias
•  (usually acquired)
•  Aching back, abdominal, and/or limb pain.
•  Headache, malaise, fever.
•  Pallor, jaundice, tachycardia.

Laboratory Findings
Signs of excessive red cell destruction
•  Hemoglobinemia/hemoglobinuria (when hemolysis is intravascular, or so
   brisk extravascularly that macrophages cannot keep up).
•  Increased serum unconjugated bilirubin (unless liver can keep up with
   excretion!).
•  Decreased free haptoglobin (a protein that binds free Hgb).
•  Increased lactate dehydrogenase (LDH) (a red cell enzyme).
•  Decreased red cell lifespan (label cells with    Chromium,
   measure t     ; rarely done because expensive, time-consuming).

Signs of accelerated erythropoiesis: reticulocytosis
1. Reticulocyte count = percentage of red blood cells that are reticulocytes    
   •  normal = 1-3%
   •  This is just a raw measurement of how many reticulocytes there are.
       It doesn't take into account things like the patient's hemoglobin, or
       the presence of shift reticulocytes (see below)
   •  To be more precise, you need to do some calculations (below)
       to account for these conditions.
2. "Corrected" reticulocyte count = reticulocyte % x Hgb/15
    •  This formula takes into account the patient's hemoglobin
       (at lower hemoglobin, should have more retics!).
3. "Reticulocyte production index" = (reticulocyte %/reticulocyte maturation
    time) x Hgb/15.
    •  This formula takes into account the fact that when the blood is
       desperate for red cells, the bone marrow starts pushing out very
       young, not-quite-mature reticulocytes into the blood (these are called
       "shift" reticulocytes).
    •  Because they are not as far along in development as normal
       reticulocytes when they are kicked out into the blood, it takes
       a little extra time in the blood before these shift reticulocytes are
       fully mature.
    •  A rough measure of this extra time is the reticulocyte maturation time.
       Normally (at Hgb of about 15), it takes 1 day for reticulocytes to
       mature in the blood into red cells.
            at Hgb of 12, it takes 1.5 days for (shift) reticulocytes to mature
            at Hgb of 8, it takes 2 days for (shift) reticulocytes to mature
            at Hgb of 5, it takes 2.5 days for (shift) reticulocytes to mature

Morphology
•  Most cases of hemolytic anemia are normochromic and normocytic
•  Spherocytes are always present, no matter what's causing the hemolysis
•  Other more specialized poikilocytes:
   •  Target cells (seen frequently in thalassemia and hemoglobinopathies)
   •  Elliptocytes (seen frequently in hereditary elliptocytosis)
   •  Sickle cells (seen in sickle cell anemia)
   •  Schistocytes, helmet cells, other fragmented red cells
       (seen in microangiopathic hemolytic anemia)
•  Signs of increased erythropoiesis:
    •  Polychromatophilia (or, if stained with supravital stain, reticulocytosis)
    •  Basophilic stippling (RNA remnants not yet removed from cell)
    •  Nucleated red blood cells (bone marrow hurrying to get red cells out
        as quickly as possible)

Important Lab Test
•  Also called the Coomb's test.
•  Mix patient's red cells with anti-IgG and anti-IgM antibodies.
•  If the red cells are coated with antibodies (as they are in some immune
   processes, see later), the anti-IgG or anti-IgM will attach to those antibodies,
   bridging the red cells and making them clump together.
•  So, a positive result (red cell clumping) means the patient's red cells are
   coated with antibodies, and the hemolysis is probably immune-related.

Diagnosis
1. Is there hemolysis? Look for:
   •  Signs of increased red cell destruction
   •  Signs of increased erythropoiesis (if hemolysis has been around
       long enough)
2. What's causing the hemolysis? Using the history, DAT, and blood smear,
   you can catogerize patients into 5 groups:
   •  Patients with known exposure to infectious or chemical agents.
   •  Patients with positive DAT (diagnosis: immune-related hemolytic anemia).
   •  Patients with negative DAT but lots of spherocytes (probable diagnosis:
       hereditary spherocytosis).
   •  Patients with negative DAT and other specific, morphologic
       abnormalities (e.g., sickle cells).
   •  Patients with negative DAT and no specific morphologic abnormalities
       (do Hgb electrophoresis).

Hemolytic anemia in a nutshell

•  Increased rate of red cell
   destruction
•  Bone marrow responds
   (usually) by increasing red
   cell production
•  Blood smear shows
   spherocytes (no matter what
   is causing the hemolysis)
51
1/2
Introduction
Anemia
  •  Iron-deficiency anemia
  •  Anemia of chronic disease
  •  Megaloblastic anemia
  •  Hemolytic anemias
      •  Hereditary spherocytosis
      •  G6PD deficiency
      •  Hemoglobinopathies
      •  Thalassemias
      •  AIHA
      •  MAHA
  •  Aplastic anemia
Benign Leukocytoses
Malignant Hematopathology
Acute Leukemia
Chronic Myeloproliferative D/o
Chronic Lymphoproliferative D/o
Lymphoma
Myeloma